Regulatory T cell in stroke: A new paradigm for immune regulation

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Chen, Sheng ^a,b   Wu, Haijian ^a   Klebe, Damon ^b   Hong, Yuan ^a   Zhang, Jianmin ^a   Tang, Jiping ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE ACTIVATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; DENDRITIC CELL; GENE MUTATION; HUMAN; IMMUNOREGULATION; MACROPHAGE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; STROKE PATIENT; T LYMPHOCYTE ACTIVATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM;

CENTRAL NERVOUS SYSTEM DISEASES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNE TOLERANCE; IMMUNOMODULATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; STROKE; T-LYMPHOCYTES, REGULATORY;

EID: 84883166846     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/689827     Document Type: Review

References (97)

1. Workman C. J., Szymczak-Workman A. L., Collison L. W., Pillai M. R., Vignali D. A. A., The development and function of regulatory T cells. Cellular and Molecular Life Sciences 2009 66 16 2603 2622 2-s2.0-68549110270 10.1007/s00018-009-0026-2
2. + regulatory T cell: a jack of all trades, master of regulation. Nature Immunology 2008 9 3 239 244 2-s2.0-39449126502 10.1038/ni1572
3. Offner H., Hurn P. D., A novel hypothesis: regulatory B lymphocytes shape outcome from experimental stroke. Translational Stroke Research 2012 3 3 324 330 2-s2.0-84860570713 10.1007/s12975-012-0187-4
4. Maes W., Verschuere T., Van Hoylandt A., Boon L., Van Gool S., Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain. Clinical and Developmental Immunology 2013 2013 6 952469 10.1155/2013/952469
5. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunological Reviews 2006 212 8 27 2-s2.0-33746342994 10.1111/j.0105-2896.2006.00427.x
6. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annual Review of Immunology 2004 22 531 562 2-s2.0-2442484053 10.1146/annurev.immunol. 21.120601.141122
7. Braga W. M. T., Atanackovic D., Colleoni G. W. B., The role of regulatory T cells and TH17 cells in multiple myeloma. Clinical and Developmental Immunology 2012 2012 4 2-s2.0-84859735292 10.1155/2012/293479 293479
8. Cusick M. F., Schiller J. J., Gill J. C., Eckels D. D., Hepatitis C virus induces regulatory T cells by naturally occurring viral variants to suppress T cell responses. Clinical and Developmental Immunology 2011 2011 15 2-s2.0-79251564716 10.1155/2011/806061 806061
9. Walsh J. T., Kipnis J., Regulatory T cells in CNS injury: the simple, the complex and the confused. Trends in Molecular Medicine 2011 17 10 541 547 2-s2.0-80053574871 10.1016/j.molmed.2011.05.012
10. He F., Balling R., The role of regulatory T cells in neurodegenerative diseases. Wiley Interdisciplinary Reviews-Systems Biology and Medicine 2013 5 2 153 180
11. Zozulya A. L., Wiendl H., The role of regulatory T cells in multiple sclerosis. Nature Clinical Practice Neurology 2008 4 7 384 398 2-s2.0-48949116961 10.1038/ncpneuro0832
12. Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T., Veltkamp R., Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine 2009 15 2 192 199 2-s2.0-59649123881 10.1038/nm.1927
13. Lowther D. E., Hafler D. A., Regulatory T cells in the central nervous system. Immunological Reviews 2012 248 1 156 169
14. Norrving B., Kissela B., The global burden of stroke and need for a continuum of care. Neurology 2013 80 3, supplement 2 S5 S12
15. Tajiri N., Dailey T., Metcalf C., In vivo animal stroke models: a rationale for rodent and non-human primate models. Translational Stroke Research 2013 4 3 308 321
16. Del Zoppo G. J., Saver J. L., Jauch E. C., Adams H. P., Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American heart association/american stroke association. Stroke 2009 40 8 2945 2948 2-s2.0-68749100878 10.1161/STROKEAHA.109.192535
17. Woodruff T. M., Thundyil J., Tang S.-C., Sobey C. G., Taylor S. M., Arumugam T. V., Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Molecular Neurodegeneration 2011 6 1, article 11 2-s2.0-78951485462 10.1186/1750-1326-6-11
18. Iadecola C., Anrather J., The immunology of stroke: from mechanisms to translation. Nature Medicine 2011 17 7 796 808 2-s2.0-79960141471 10.1038/nm.2399
19. Hammond M. D., Ai Y., Sansing L. H., Gr1+ macrophages and dendritic cells dominate the inflammatory infiltrate 12 h after experimental intracerebral hemorrhage. Translational Stroke Research 2012 3 1 s125 s131 2-s2.0-84859910053 10.1007/s12975-012-0174-9
20. Mccombe P. A., Read S. J., Immune and inflammatory responses to stroke: good or bad? International Journal of Stroke 2008 3 4 254 265 2-s2.0-52249113133 10.1111/j.1747-4949.2008.00222.x
21. Offner H., Subramanian S., Parker S. M., Afentoulis M. E., Vandenbark A. A., Hurn P. D., Experimental stroke induces massive, rapid activation of the peripheral immune system. Journal of Cerebral Blood Flow and Metabolism 2006 26 5 654 665 2-s2.0-33646382597 10.1038/sj.jcbfm.9600217
22. Emsley H. C. A., Hopkins S. J., Post-stroke immunodepression and infection: an emerging concept. Infectious Disorders 2010 10 2 91 97 2-s2.0-77958032499
23. Fathali N., Ostrowski R. P., Hasegawa Y., Splenic immune cells in experimental neonatal hypoxia-ischemia. Translational Stroke Research 2013 4 2 208 219
24. Macrez R., Ali C., Toutirais O., Le Mauff B., Defer G., Dirnagl U., Vivien Denis D., Stroke and the immune system: from pathophysiology to new therapeutic strategies. The Lancet Neurology 2011 10 5 471 480 2-s2.0-79954579638 10.1016/S1474-4422(11)70066-7
25. Yoo S. W., Chang D. Y., Lee H. S., Immune following suppression mesenchymal stem cell transplantation in the ischemic brain is mediated by TGF-beta. Neurobiology of Disease 2013 58C 249 257 10.1016/j.nbd.2013.06.001
26. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A. C., Nodin C., Ståhlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J. P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., Pekny M., Protective role of reactive astrocytes in brain ischemia. Journal of Cerebral Blood Flow and Metabolism 2008 28 3 468 481 2-s2.0-39749132193 10.1038/sj.jcbfm.9600546
27. + regulatory T-cells in cerebral ischemic stroke. Metabolic Brain Disease 2011 26 1 87 90 2-s2.0-79955083477 10.1007/s11011-010- 9226-6
28. Kleinschnitz C., Kraft P., Dreykluft A., Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013 121 4 679 691
29. Jenabian M. A., Ancuta P., Gilmore N., Routy J. P., Regulatory T cells in HIV infection: can immunotherapy regulate the regulator? Clinical and Developmental Immunology 2012 2012 12 908314 10.1155/2012/908314
30. + T regulatory cell-mediated suppression. Immunity 2009 30 5 636 645 2-s2.0-65549136983 10.1016/j.immuni. 2009.04.010
31. Corthay A., How do regulatory t cells work? Scandinavian Journal of Immunology 2009 70 4 326 336 2-s2.0-70049095101 10.1111/j.1365-3083.2009.02308.x
32. Schmetterer K. G., Neunkirchner A., Pickl W. F., Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. The FASEB Journal 2012 26 6 2253 2276
33. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α -chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 1995 155 3 1151 1164 2-s2.0-0029150110
34. Nik Tavakoli N., Hambly B. D., Sullivan D. R., Bao S., Forkhead box protein 3: essential immune regulatory role. International Journal of Biochemistry and Cell Biology 2008 40 11 2369 2373 2-s2.0-48249142722 10.1016/j.biocel.2007.10.004
35. + regulatory T cells in immunological tolerance to self and non-self. Nature Immunology 2005 6 4 345 352 2-s2.0-16844365788 10.1038/ni1178
36. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. Journal of Experimental Medicine 2005 201 5 723 735 2-s2.0-15444374646 10.1084/jem.20041982
37. Jin B., Sun T., Yu X. H., Yang Y. X., Yeo A. E., The effects of TLR activation on T-cell development and differentiation. Clinical and Developmental Immunology 2012 2012 32 836485 10.1155/2012/836485
38. + T-regulatory cells: toward therapy for human diseases. Immunological Reviews 2008 223 1 391 421 2-s2.0-47249102067 10.1111/j.1600-065X.2008.00634.x
39. Li B., Samanta A., Song X., Furuuchi K., Iacono K. T., Kennedy S., Katsumata M., Saouaf S. J., Greene M. I., FOXP3 ensembles in T-cell regulation. Immunological Reviews 2006 212 99 113 2-s2.0-33746342752 10.1111/j.0105-2896. 2006.00405.x
40. Oh U., Grant C., Griffith C., Fugo K., Takenouchi N., Jacobson S., Reduced Foxp3 protein expression is associated with inflammatory disease during human T lymphotropic virus type 1 infection. Journal of Infectious Diseases 2006 193 11 1557 1566 2-s2.0-33646906178 10.1086/503874
41. Gambineri E., Torgerson T. R., Ochs H. D., Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Current Opinion in Rheumatology 2003 15 4 430 435 2-s2.0-0038434099 10.1097/00002281-200307000-00010
42. Bettelli E., Dastrange M., Oukka M., Foxp3 interacts with nuclear factor of activated T cells and NF- B to repress cytokine gene expression and effector functions of T helper cells. Proceedings of the National Academy of Sciences of the United States of America 2005 102 14 5138 5143 2-s2.0-17044393922 10.1073/pnas.0501675102
43. Schubert L. A., Jeffery E., Zhang Y., Ramsdell F., Ziegler S. F., Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. Journal of Biological Chemistry 2001 276 40 37672 37679 2-s2.0-0035813231 10.1074/jbc.M104521200
44. Grant C., Oh U., Fugo K., Takenouchi N., Griffith C., Yao K., Newhook T. E., Ratner L., Jacobson S., Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathogens 2006 2 4 e33 2-s2.0-33646699097 10.1371/journal.ppat.0020033
45. Villaseñor J., Benoist C., Mathis D., AIRE and APECED: molecular insights into an autoimmune disease. Immunological Reviews 2005 204 156 164 2-s2.0-16244367143 10.1111/j.0105-2896.2005.00246.x
46. Ziegler S. F., FOXP3: of mice and men. Annual Review of Immunology 2006 24 209 226 2-s2.0-33646168597 10.1146/annurev.immunol.24.021605.090547
47. Scalapino K. J., Daikh D. I., CTLA-4: a key regulatory point in the control of autoimmune disease. Immunological Reviews 2008 223 1 143 155 2-s2.0-47249153181 10.1111/j.1600-065X.2008.00639.x
48. + regulatory T cells. International Immunology 2008 20 4 471 483 2-s2.0-41149091775 10.1093/intimm/dxn007
49. Sansom D. M., Walker L. S. K., The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunological Reviews 2006 212 131 148 2-s2.0-33746336533 10.1111/j.0105-2896.2006.00419.x
50. + regulatory T cells are dependent on CTLA-4 expression. European Journal of Immunology 2004 34 12 3485 3496 2-s2.0-10944233989 10.1002/eji.200324632
51. Kolar P., Knieke K., Hegel J. K. E., Quandt D., Burmester G.-R., Hoff H., Brunner-Weinzierl M. C., CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis and Rheumatism 2009 60 1 123 132 2-s2.0-58249112156 10.1002/art.24181
52. Loser K., Beissert S., Regulatory T cells: banned cells for decades. Journal of Investigative Dermatology 2012 132 3, part 2 864 871 2-s2.0-84856865635 10.1038/jid.2011.375
53. + regulatory T cell function. Science 2008 322 5899 271 275 2-s2.0-53749094183 10.1126/science.1160062
54. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. Journal of Experimental Medicine 2000 192 2 303 309 2-s2.0-0034679560 10.1084/jem.192.2.303
55. + regulatory T cells exert in vitro suppressive activity independent of CTLA-4. International Immunology 2005 17 4 421 427 2-s2.0-17644376164 10.1093/intimm/dxh221
56. Gorelik L., Flavell R. A., Transforming growth factor- β in T-cell biology. Nature Reviews Immunology 2002 2 1 46 53 2-s2.0-0036372440
57. + regulatory T cells and immune tolerance. Autoimmunity 2006 39 4 269 276 2-s2.0-33746973702 10.1080/08916930600753903
58. - T cells through Foxp3 induction and down-regulation of Smad7. Journal of Immunology 2004 172 9 5149 5153 2-s2.0-2142645808
59. + regulatory T cells. Journal of Experimental Medicine 2005 201 7 1061 1067 2-s2.0-17144400393 10.1084/jem.20042276
60. Shi Y., Fukuoka M., Li G., Liu Y., Chen M., Konviser M., Chen X., Opavsky M. A., Liu P. P., Regulatory T cells protect mice against coxsackievirus- induced myocarditis through the transforming growth factor β -coxsackie-adenovirus receptor pathway. Circulation 2010 121 24 2624 2634 2-s2.0-77954086395 10.1161/CIRCULATIONAHA.109.893248
61. Grilli M., Barbieri I., Basudev H., Brusa R., Casati C., Lozza G., Ongini E., Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. European Journal of Neuroscience 2000 12 7 2265 2272 2-s2.0-0033930743 10.1046/j.1460-9568.2000.00090.x
62. Spera P. A., Ellison J. A., Feuerstein G. Z., Barone F. C., IL-10 reduces rat brain injury following focal stroke. Neuroscience Letters 1998 251 3 189 192 2-s2.0-0032584685 10.1016/S0304-3940(98)00537-0
63. Ouyang W., Rutz S., Crellin N. K., Valdez P. A., Hymowitz S. G., Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual Review of Immunology 2011 29 71 109 2-s2.0-79953048089 10.1146/annurev-immunol-031210-101312
64. Li P., Gan Y., Sun B. L., Adoptive regulatory T-cell therapy protects against cerebral ischemia. Annals of Neurology 2013 10.1002/ana.23815
65. + immunoregulatory T cells is antigen nonspecific. Journal of Immunology 2000 164 1 183 190 2-s2.0-0033985780
66. Jadidi-Niaragh F., Mirshafiey A., Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis. Immunopharmacology and Immunotoxicology 2011 33 3 545 567 2-s2.0-79961140179 10.3109/08923973.2010. 513391
67. Faria A. M. C., Weiner H. L., Oral tolerance: therapeutic implications for autoimmune diseases. Clinical and Developmental Immunology 2006 13 2-4 143 157 2-s2.0-33845662118 10.1080/17402520600876804
68. + regulatory T cells in patients with multiple sclerosis. Journal of Experimental Medicine 2004 199 7 971 979 2-s2.0-1842732224 10.1084/jem.20031579
69. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. Journal of Immunology 2002 169 9 4712 4716 2-s2.0-0036838536
70. + regulatory T cells in an animal model of Parkinson's disease. Journal of Leukocyte Biology 2007 82 5 1083 1094 2-s2.0-36249032567 10.1189/jlb.0507296
71. + T cells. Journal of Proteome Research 2009 8 7 3497 3511 2-s2.0-67650351515 10.1021/pr9001614
72. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I. R., Schwartz M., Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nature Medicine 1999 5 1 49 55 2-s2.0-0033049143 10.1038/4734
73. + regulatory T cells in neurodegeneration: a dialogue with microglia. Proceedings of the National Academy of Sciences of the United States of America 2004 101 2 14663 14669 2-s2.0-5144227225 10.1073/pnas. 0404842101
74. + regulatory T cells suppress the ability to withstand injury to the central nervous system. Proceedings of the National Academy of Sciences of the United States of America 2002 99 24 15620 15625 2-s2.0-0037180556 10.1073/pnas.232565399
75. + regulatory T cells in a murine model of HIV-1-associated neurodegeneration. Journal of Immunology 2009 182 6 3855 3865 2-s2.0-65449173545 10.4049/jimmunol.0803330
76. Gelderblom M., Leypoldt F., Steinbach K., Behrens D., Choe C.-U., Siler D. A., Arumugam T. V., Orthey E., Gerloff C., Tolosa E., Magnus T., Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009 40 5 1849 1857 2-s2.0-65549130913 10.1161/STROKEAHA.108.534503
77. Yan J., Greer J. M., Etherington K., Cadigan G. P., Cavanagh H., Henderson R. D., O'Sullivan J. D., Pandian J. D., Read S. J., McCombe P. A., Immune activation in the peripheral blood of patients with acute ischemic stroke. Journal of Neuroimmunology 2009 206 1-2 112 117 2-s2.0-58149229352 10.1016/j.jneuroim.2008.11.001
78. Urra X., Cervera Á., Villamor N., Planas A. M., Chamorro Á., Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 2009 158 3 1174 1183 2-s2.0-59349112750 10.1016/j.neuroscience.2008.06.014
79. Yan J., Read S. J., Henderson R. D., Hull R., O'Sullivan J. D., McCombe P. A., Greer J. M., Frequency and function of regulatory T cells after ischaemic stroke in humans. Journal of Neuroimmunology 2012 243 1-2 89 94 2-s2.0-84856955229 10.1016/j.jneuroim.2011.12.019
80. Stubbe T., Ebner F., Richter D., Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO. Journal of Cerebral Blood Flow & Metabolism 2013 33 1 37 47
81. Hug A., Liesz A., Muerle B., Zhou W., Ehrenheim J., Lorenz A., Dalpke A., Veltkamp R., Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia. Stroke 2011 42 12 3580 3586 2-s2.0-84856209332 10.1161/STROKEAHA.111.620948
82. +T cells are associated with an increased risk for development of myocardial infarction but not for stroke. Arteriosclerosis Thrombosis and Vascular Biology 2012 32 8 2000 2007
83. Chen Y., Kuchroo V. K., Inobe J.-I., Hafler D. A., Weiner H. L., Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994 265 5176 1237 1240 2-s2.0-0028037782
84. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997 389 6652 737 742 2-s2.0-0030704726 10.1038/39614
85. Chen Y., Ruetzler C., Pandipati S., Spatz M., McCarron R. M., Becker K., Hallenbeck J. M., Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 15107 15112 2-s2.0-0345598137 10.1073/pnas.2436538100
86. Gee J. M., Kalil A., Thullbery M., Becker K. J., Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke 2008 39 5 1575 1582 2-s2.0-44449167217 10.1161/STROKEAHA.107.501486
87. Gee J. M., Zierath D., Hadwin J., Long term immunologic consequences of experimental stroke and mucosal tolerance. Experimental & Translational Stroke Medicine 2009 1 3
88. Ishibashi S., Maric D., Mou Y., Ohtani R., Ruetzler C., Hallenbeck J. M., Mucosal tolerance to E-selectin promotes the survival of newly generated neuroblasts via regulatory T-cell induction after stroke in spontaneously hypertensive rats. Journal of Cerebral Blood Flow and Metabolism 2009 29 3 606 620 2-s2.0-61349199500 10.1038/jcbfm.2008.153
89. Offner H., Subramanian S., Parker S. M., Wang C., Afentoulis M. E., Lewis A., Vandenbark A. A., Hurn P. D., Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. Journal of Immunology 2006 176 11 6523 6531 2-s2.0-33646874015
90. Saino O., Taguchi A., Nakagomi T., Nakano-Doi A., Kashiwamura S.-I., Doe N., Nakagomi N., Soma T., Yoshikawa H., Stern D. M., Okamura H., Matsuyama T., Immunodeficiency reduces neural stem/progenitor cell apoptosis and enhances neurogenesis in the cerebral cortex after stroke. Journal of Neuroscience Research 2010 88 11 2385 2397 2-s2.0-77955370220 10.1002/jnr.22410
91. Chang L., Chen Y., Li J., Liu Z., Wang Z., Chen J., Cao W., Xu Y., Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke. Brain, Behavior, and Immunity 2011 25 2 260 269 2-s2.0-78651420036 10.1016/j.bbi.2010.09.017
92. Choi D.-H., Lim J. H., Lee K.-H., Kim M. Y., Kim H. Y., Shin C. Y., Hana S.-H., Lee J., Effect of 710 nm visible light irradiation on neuroprotection and immune function after stroke. NeuroImmunoModulation 2012 19 5 267 276 2-s2.0-84859125312 10.1159/000335547
93. Wang M., Wang Y., He J., Albumin induces neuroprotection against ischemic stroke by altering Toll-like receptor 4 and regulatory T cells in mice. CNS & Neurological Disorders 2013 12 2 220 227
94. Yamaguchi T., Kishi A., Osaki M., Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression. Proceedings of the National Academy of Sciences of the United States of America 2013 110 23 E2116 E2125
95. + regulatory T cells and the inhibition of osteoclastogenesis. Immunology Letters 2012 148 1 59 68
96. Wei S., Kryczek I., Zou W., Regulatory T-cell compartmentalization and trafficking. Blood 2006 108 2 426 431 2-s2.0-33745968543 10.1182/blood-2006-01- 0177
97. Lapchak P. A., Zhang J. H., Noble-Haeusslein L. J., RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Translational Stroke Research 2013 4 3 279 285